Our Technology
One of the fundamental challenges of many natural health ingredients including cannabinoids includes its poor bioavailability. Due to its lipophilic nature, human body has hard time absorbing them.
Advanced patent-pending delivery system, Solid State Reactive Mixing (SSRM), invented by Folium Labs presents a novel solution that human bodies can simply absorb more and waste less.
Commercial Applications
Our SSRM technology comes in powder formulations, hard-pressed tablet, gummy tablets, liquid formulations, functional foods and beverages
Research
Folium Labs Inc. tested SSRM on a number of compounds in pre-clinical studies and achieved impressive results
Joint Venture / Licensing
Our SSRM technology is highly versatile and scalable and will allow our partners to offer highly differentiated products for their target consumers.
Vitamins & Minerals
SSRM technology can be applied to a wide array of ingredients – vitamins, minerals, and botanicals
Botanical Extracts
SSRM technology can be successfully deployed in the botanical extracts applications
About Us
We are Montreal-based biotechnology company focused on the development and commercialization of proprietary delivery platform that provides enhanced bioavailability and targeted delivery of active ingredients.
Our Partners and Supporters
National Research Council Canada / Conseil national de recherches Canada
District 3 Innovation Hub, Montreal
Ministère de l'Économie et de l'Innovation
Investissement Québec
PME MTL, Montreal
TransBIOTech
CÉPROCQ Centre d’études des procédés chimiques du Québec
Natural Products Canada
Mitacs
News
Folium Labs Inc. is proud to be among the Top Toronto Pharmaceutical Startups.
BestStartup.ca included Folium Labs on the Top 78 Pharmaceutical Startups and Companies in Toronto
(2021). “These startups and companies are taking a variety of approaches to innovate the Pharmaceutical industry, but are all exceptional companies well worth a follow.
Therapeutic benefits of medicinal cannabinoids and current delivery method
Aya Sakaya, Folium Labs Download the article in PDF format Introduction Cannabinoids commonly refer to compounds extracted from, among other cannabis plants, Cannabis sativa and Cannabis indica. The most studied and researched cannabinoids are delta-9-tetrahydrocannabinol
Current Advances and Challenges of Drug and Nutraceutical Delivery Technologies
Aya Sakaya, Folium Labs Download the article in PDF format Introduction Drug delivery technologies are platforms that enable the conversion of potential therapeutics into successful therapies. These biotechnologies have allowed to improve patient health through
Unlocking Benefits from Medicinal Mushroom
Medicinal mushrooms have been in use for hundreds of years, especially in East Asia. These mushrooms have been marveled for their nutritional value as well as health benefits, including antimicrobial, anti-inflammatory, and anti-cancer abilities [1].
Iron supplementation
Sufficient intake of micronutrients is critical for healthy development and growth of children and overall health maintenance in adulthood. When inadequate consumption of essential micronutrients is prolonged over time, it could lead to deficiencies and
Investor
Folium Labs Inc. is focused on the technologies that drastically enhance bioavailability and efficacy of natural health ingredients and cannabinoids.
SSRM: Patent-pending proprietary technology
Attractive Market Size and Market Growth: TAM over $100B, CAGR 7-9%
Scalability : Versatile technology that can be applied to various ingredients and formats presenting long-term sustainable growth